These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 6774851

  • 1. Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
    Nilsson O, Englund D, Weiner E, Victor A.
    Contraception; 1980 Jul; 22(1):71-83. PubMed ID: 6774851
    [Abstract] [Full Text] [Related]

  • 2. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
    Johannisson E, Brosens I, Cornillie F, Elder M, White J, Sheppard B, Hourihan H, d'Arcangues C, Belsey EM.
    Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
    [Abstract] [Full Text] [Related]

  • 3. The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
    Landgren BM, Johannisson E, Aedo AR, Kumar A, Shi YE.
    Contraception; 1989 Mar; 39(3):275-89. PubMed ID: 2496951
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring.
    White JO, Sullivan MH, Patel L, Croxtall JD, d'Arcangues C, Belsey EM, Elder MG.
    Contraception; 1991 Apr; 43(4):401-12. PubMed ID: 1649733
    [Abstract] [Full Text] [Related]

  • 5. [Histochemical and histological investigations on the human fallopian tube under different hormonal influences. I. Demonstration of ATPase with special reference to reactive ciliated cells (author's transl)].
    Kugler P, Wrobel KH, Wallner HJ, Heinzmann U.
    Arch Gynakol; 1976 Dec 10; 221(4):345-66. PubMed ID: 137700
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D, Antoniou G, Karakitsos P, Kalogirou O, Antoniou D, Giannikos L.
    Int J Fertil Menopausal Stud; 1996 Dec 10; 41(6):522-7. PubMed ID: 9010746
    [Abstract] [Full Text] [Related]

  • 7. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
    Landgren BM, Johannisson E, Xing S, Aedo AR, Diczfalusy E.
    Contraception; 1985 Dec 10; 32(6):581-601. PubMed ID: 3937664
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
    Toddyvalla V, Johannisson E, Landgren BM, Cekan SZ, Diczfalusy E.
    Contraception; 1983 Jul 10; 28(1):21-39. PubMed ID: 6414759
    [Abstract] [Full Text] [Related]

  • 9. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 Jul 10; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 10. Endometrial vascular features prior to and following exposure to levonorgestrel.
    Hourihan HM, Sheppard BL, Belsey EM, Brosens IA.
    Contraception; 1991 Apr 10; 43(4):375-85. PubMed ID: 1906793
    [Abstract] [Full Text] [Related]

  • 11. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
    Wonodirekso S, Au CL, Hadisaputra W, Affandi B, Rogers PA.
    Contraception; 1993 Nov 10; 48(5):481-93. PubMed ID: 7506133
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL, Affandi B, Rogers PA.
    Contraception; 1994 Nov 10; 50(5):477-89. PubMed ID: 7859456
    [Abstract] [Full Text] [Related]

  • 13. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul 10; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 14. Lysosomal enzymes in the human endometrium: a biochemical study in untreated and levonorgestrel-treated women.
    Cornillie F, Brosens I, Belsey EM, Marbaix E, Baudhuin P, Courtoy PJ.
    Contraception; 1991 Apr 10; 43(4):387-400. PubMed ID: 1906794
    [Abstract] [Full Text] [Related]

  • 15. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W, Reinprayoon D, Pruksananonda K, Niruttisard S, Triratanachat S, Leepipatpaiboon S, Wannakrairot P.
    Hum Reprod; 1996 Oct 10; 11 Suppl 2():115-23. PubMed ID: 8982753
    [Abstract] [Full Text] [Related]

  • 16. Endometrial morphology during a normophasic and a triphasic regimen: a comparison.
    Wynants P, Ide P.
    Contraception; 1986 Feb 10; 33(2):149-57. PubMed ID: 2938885
    [Abstract] [Full Text] [Related]

  • 17. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G, Kalogirou D, Karakitsos P, Antoniou D, Kalogirou O, Giannikos L.
    Maturitas; 1997 Mar 10; 26(2):103-11. PubMed ID: 9089559
    [Abstract] [Full Text] [Related]

  • 18. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD, Taylor RN, Klaisle C, Bottles K, Zaloudek C.
    Contraception; 1996 Feb 10; 53(2):97-100. PubMed ID: 8838486
    [Abstract] [Full Text] [Related]

  • 19. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
    Roy S, Stanczyk F, Mishell DR, Lumkin M, Gentzschein E.
    Contraception; 1980 Jun 10; 21(6):595-615. PubMed ID: 6775868
    [Abstract] [Full Text] [Related]

  • 20. Short-term treatment with levonorgestrel does not antagonize the ethinyl estradiol-induced increase of uterine blood flow in postmenopausal women.
    Entezami M, Heger-Mahn D, Ebert A, Halis G, Lübbert H.
    Contraception; 1997 Sep 10; 56(3):181-3. PubMed ID: 9347210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.